In this study, we used comprehensive scRNA-seq and ST analysis to identify changes in the expression of apoptosis-related genes after EGFR-TKI treatment and to assess tumor heterogeneity in EGFR-mutated lung cancer. This evidence concerns the gene EGFR and lung cancer.